Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Help & FAQ
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press / Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
New therapies for familial hypercholesterolemia
John Burnett
,
Gerald Watts
Graduate Research School
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New therapies for familial hypercholesterolemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Bile Acid
79%
Anticholesteremic Agent
53%
Cholesteryl Ester
45%
Squalene
44%
Triglyceride
36%
Cholesterol
30%
Disorder
29%
Protein
28%
Drug
18%
Medicine & Life Sciences
Hyperlipoproteinemia Type II
85%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
44%
Farnesyl-Diphosphate Farnesyltransferase
38%
sodium-bile acid cotransporter
37%
Anticholesteremic Agents
33%
Cardiovascular Diseases
33%
Bile Acids and Salts
23%
Genetic Therapy
21%
Coronary Artery Disease
19%
Pharmaceutical Preparations
19%
Cholesterol
16%
Technology
15%
Liver
11%
Therapeutics
11%